New HIV vaccine candidates enter human safety testing
NCT ID NCT05471076
First seen Feb 03, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This early-stage study tests whether two experimental HIV vaccine priming regimens are safe and can activate special immune cells that make broad antibodies. 52 healthy adults without HIV will receive the vaccines, with some getting a booster shot later. The goal is to see if the vaccines can teach the body to make antibodies that work against many HIV strains.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS
Birmingham, Alabama, 35222, United States
-
Bridge HIV CRS
San Francisco, California, 94102, United States
-
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
Boston, Massachusetts, 02115-6110, United States
-
Columbia P&S CRS
New York, New York, 10032, United States
-
Seattle Vaccine and Prevention CRS
Seattle, Washington, 98104, United States
-
The Ponce de Leon Center CRS
Atlanta, Georgia, 30308-2012, United States
Conditions
Explore the condition pages connected to this study.